| Date | Description |
|---|
| 2024-03-26 |
delete chiefcommercialofficer Fuqiang Zhang |
| 2024-03-26 |
delete person Fuqiang Zhang |
| 2024-03-26 |
insert investor Equiniti Trust Company, LLC |
| 2023-08-12 |
insert career_emails hr@casi.cn |
| 2023-08-12 |
delete index_pages_linkeddomain nasdaq.com |
| 2023-08-12 |
delete source_ip 192.169.150.185 |
| 2023-08-12 |
insert email hr@casi.cn |
| 2023-08-12 |
insert index_pages_linkeddomain pousion.com |
| 2023-08-12 |
insert index_pages_linkeddomain sec.gov |
| 2023-08-12 |
insert source_ip 47.243.103.245 |
| 2023-08-12 |
update robots_txt_status www.casipharmaceuticals.com: 404 => 200 |
| 2023-03-27 |
delete otherexecutives Franklin C. Salisbury |
| 2023-03-27 |
delete otherexecutives James E. Goldschmidt |
| 2023-03-27 |
delete otherexecutives James Huang |
| 2023-03-27 |
delete otherexecutives Junping Chen |
| 2023-03-27 |
delete otherexecutives Quan Zhou |
| 2023-03-27 |
delete otherexecutives Rajesh C. Shrotriya |
| 2023-03-27 |
insert chairman Thomas Folinsbee |
| 2023-03-27 |
insert chairman Zhenbo Su |
| 2023-03-27 |
insert chiefcommercialofficer Fuqiang Zhang |
| 2023-03-27 |
insert chieflegalofficer Wei Gao |
| 2023-03-27 |
insert coo Chunhua Wang |
| 2023-03-27 |
insert coo Wei Gao |
| 2023-03-27 |
insert otherexecutives Zhenbo Su |
| 2023-03-27 |
delete associated_investor Kleiner Perkins Caufield & Byers |
| 2023-03-27 |
delete associated_investor Vivo Ventures |
| 2023-03-27 |
delete person Franklin C. Salisbury |
| 2023-03-27 |
delete person James E. Goldschmidt |
| 2023-03-27 |
delete person James Huang |
| 2023-03-27 |
delete person Junping Chen |
| 2023-03-27 |
delete person Quan Zhou |
| 2023-03-27 |
delete person Rajesh C. Shrotriya |
| 2023-03-27 |
insert person Chunhua Wang |
| 2023-03-27 |
insert person Fuqiang Zhang |
| 2023-03-27 |
insert person Kun Qian |
| 2023-03-27 |
insert person Thomas Folinsbee |
| 2023-03-27 |
insert person Wei Gao |
| 2023-03-27 |
insert person Xuebo Zeng |
| 2023-03-27 |
insert person Zhenbo Su |
| 2023-03-27 |
update person_description Wei-Wu He => Wei-Wu He |
| 2023-03-27 |
update person_title Cissy Wang: Chief Operating Officer; Chief Operating Officer of CASI Pharmaceuticals ( China ) Co => Chief Operating Officer |
| 2022-10-19 |
delete source_ip 64.207.139.211 |
| 2022-10-19 |
insert source_ip 192.169.150.185 |
| 2021-07-29 |
insert chiefcommercialofficer Thomas Zhang |
| 2021-07-29 |
update person_title Thomas Zhang: General Manager, Sales & Marketing => Chief Commercial Officer |
| 2021-04-25 |
delete cfo Weihao Xu |
| 2021-04-25 |
delete person Weihao Xu |
| 2021-02-02 |
insert cfo Weihao Xu |
| 2021-02-02 |
insert otherexecutives Junping Chen |
| 2021-02-02 |
delete index_pages_linkeddomain youtube.com |
| 2021-02-02 |
insert person Junping Chen |
| 2021-02-02 |
insert person Weihao Xu |
| 2020-07-22 |
update person_title Cissy Wang: Chief Operating Officer of CASI Pharmaceuticals ( Beijing ) Co => Chief Operating Officer of CASI Pharmaceuticals ( China ) Co; Chief Operating Officer, CASI Pharmaceuticals ( China ) Co., Ltd |
| 2020-07-22 |
update person_title Thomas Zhang: General Manager, Sales & Marketing, CASI Pharmaceuticals ( Beijing ) Co => General Manager, Sales & Marketing, CASI Pharmaceuticals ( China ) Co., Ltd |
| 2020-03-22 |
delete cfo George Chi |
| 2020-03-22 |
delete person George Chi |
| 2020-02-20 |
delete alias CASI (Beijing) Pharmaceuticals Co., Ltd. |
| 2020-02-20 |
insert alias CASI Pharmaceuticals (China) Co., Ltd. |
| 2020-01-16 |
delete otherexecutives Ken K. Ren |
| 2020-01-16 |
delete person Ken K. Ren |
| 2019-11-11 |
delete source_ip 70.32.68.165 |
| 2019-11-11 |
insert source_ip 64.207.139.211 |
| 2019-10-12 |
insert president Larry Zhang |
| 2019-10-12 |
delete index_pages_linkeddomain media-server.com |
| 2019-10-12 |
delete management_pages_linkeddomain entremed.com |
| 2019-10-12 |
insert index_pages_linkeddomain youtube.com |
| 2019-10-12 |
insert person Cissy Wang |
| 2019-10-12 |
insert person Thomas Zhang |
| 2019-10-12 |
update description |
| 2019-10-12 |
update person_title Larry Zhang: null => President; Member of the Management Team |
| 2019-09-11 |
insert career_pages_linkeddomain casipharma.com.cn |
| 2019-09-11 |
insert career_pages_linkeddomain nasdaq.com |
| 2019-09-11 |
insert contact_pages_linkeddomain nasdaq.com |
| 2019-09-11 |
insert index_pages_linkeddomain casipharma.com.cn |
| 2019-09-11 |
insert index_pages_linkeddomain media-server.com |
| 2019-09-11 |
insert index_pages_linkeddomain nasdaq.com |
| 2019-09-11 |
insert management_pages_linkeddomain casipharma.com.cn |
| 2019-09-11 |
insert management_pages_linkeddomain nasdaq.com |
| 2019-09-11 |
insert partner_pages_linkeddomain casipharma.com.cn |
| 2019-09-11 |
insert partner_pages_linkeddomain nasdaq.com |
| 2019-07-11 |
update description |
| 2019-04-05 |
insert ceo Wei-Wu He |
| 2019-04-05 |
update person_description Wei-Wu He => Wei-Wu He |
| 2019-04-05 |
update person_title Wei-Wu He: Chairman; Executive Chairman; Director => Chairman; Chief Executive Officer; Director |
| 2018-12-15 |
delete address FullLink Plaza Suite B1214, B1215
18 Chaoyangmenwai Street,
Chaoyang, Beijing, 100020, China |
| 2018-12-15 |
delete alias CASI (Beijing) Pharmaceuticals, Inc. |
| 2018-12-15 |
delete person Sara B. Capitelli |
| 2018-12-15 |
insert address Tower 1, No.81 Jianguo Road
Chaoyang District, Beijing, 100025, China |
| 2018-12-15 |
insert alias CASI (Beijing) Pharmaceuticals Co., Ltd. |
| 2018-12-15 |
insert person George Chi |
| 2018-12-15 |
insert person Larry Zhang |
| 2018-03-08 |
update person_description James E. Goldschmidt => James E. Goldschmidt |
| 2018-03-08 |
update person_description James Huang => James Huang |
| 2017-09-26 |
update person_description Ken K. Ren => Ken K. Ren |
| 2017-06-01 |
update website_status FailedRobots => OK |